Biotech · Private company
Celltrion
Track this companyFree. Adds Celltrion to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- CT-P13 SC (Infliximab)Phase 3 · Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- CT-G20Phase 1 · Cardiomyopathy, Hypertrophic ObstructiveClinicalTrials.gov · fetched Nov 12, 2026
- CT-P13 SC Auto-injectorPhase 1 · Health, SubjectiveClinicalTrials.gov · fetched Nov 12, 2026
- CT-P13 SC Pre-filled SyringePhase 1 · Health, SubjectiveClinicalTrials.gov · fetched Nov 12, 2026
- CT-P17Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Zymfentra (Infliximab-dyyb) REal World Cohort STudyRECRUITING · started Nov 20, 2025ClinicalTrials.gov NCT07237516 · fetched Nov 12, 2026
- A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic CardiomyopathyPHASE1 · TERMINATED · started Oct 23, 2020ClinicalTrials.gov NCT04418297 · fetched Nov 12, 2026
- CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)PHASE3 · COMPLETED · started Oct 28, 2019ClinicalTrials.gov NCT03945019 · fetched Nov 12, 2026
- To Compare the Pharmacokinetics and Safety of the Auto-injector and Pre-filled Syringe of CT-P17PHASE1 · COMPLETED · started Jun 21, 2019ClinicalTrials.gov NCT04295356 · fetched Nov 12, 2026
- CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy SubjectsPHASE1 · COMPLETED · started Feb 21, 2018ClinicalTrials.gov NCT03446976 · fetched Nov 12, 2026